Related Experiment Video
Updated: Jan 15, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
A Rare Case of Pediatric Pulmonary Sarcoidosis Without Lymph Node Involvement Presenting With Centrilobular
Diane Choi1, Julia Small2, Denzil Reid3
1Department of Pediatrics, UMass Chan Medical School - Baystate, Springfield, USA.
Abstract:
A 17-year-old previously healthy male presented with acute hypoxic respiratory failure after one month of progressively worsening dyspnea on exertion, non-productive cough, fevers, and weight loss. He was initially discharged on oral steroids with a working diagnosis of cryptogenic organizing pneumonia, but was readmitted after one month for acute hypoxic respiratory failure. Extensive laboratory workup, including serum angiotensin converting enzyme level, hypersensitivity pneumonitis panel, and bronchoalveolar lavage fluid cultures, was normal. Computed tomography scan of the chest revealed diffuse centrilobular ground-glass opacities and a 4-mm solid right lower lobe pulmonary nodule, and he underwent a video-assisted thoracoscopic surgery (VATS) procedure with segmental resection of the lingula. Pathology ultimately showed non-necrotizing granulomatous inflammation in the interstitium of the lung parenchyma, airways, and blood vessels, consistent with sarcoidosis. Diagnosis of interstitial lung disease is difficult when histologic diagnosis requires an invasive, costly VATS biopsy, but prompt recognition of sarcoidosis is critical to prevent potentially fatal pulmonary fibrosis or cardiac sarcoidosis. To our knowledge, this is the first case report of pediatric pulmonary sarcoidosis with ground-glass opacities lacking any lymphadenopathy, skin, or neurologic manifestations.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Other Pulmonary Disorders
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...